7 research outputs found
DAAHCVGNTablesIFNmodified – Supplemental material for Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up
<p>Supplemental material, DAAHCVGNTablesIFNmodified for Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up by Fabrizio Fabrizi, Alessio Aghemo, Pietro Lampertico, Mirella Fraquelli, Donata Cresseri, Gabriella Moroni, Patrizia Passerini, Francesca M Donato, Piergiorgio Messa in The International Journal of Artificial Organs</p
Cirrhosis Discriminate Score (CDS) calculation.
<p>Cirrhosis Discriminate Score (CDS) calculation.</p
Non-invasive tests (NITs) values distribution at baseline and after an SVR.
<p>Non-invasive tests (NITs) values distribution at baseline and after an SVR.</p
Non-invasive tests (NITs) values before and after treatment.
<p>Non-invasive tests (NITs) values before and after treatment.</p
Non-invasive Tests (NITs) values stratification according to post-SVR fibrosis stage.
<p>Non-invasive Tests (NITs) values stratification according to post-SVR fibrosis stage.</p
Median<sup>#</sup> NIT values at post-SVR liver biopsy and reference cut-offs for the diagnosis of cirrhosis.
<p>Median<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155967#t003fn001" target="_blank"><sup>#</sup></a> NIT values at post-SVR liver biopsy and reference cut-offs for the diagnosis of cirrhosis.</p
Patients' characteristics at the time of post-SVR liver biopsy.
<p>Patients' characteristics at the time of post-SVR liver biopsy.</p